TCTMD

Preventive VT Ablation Before ICD Helps High-risk Ischemic Cardiomyopathy Patients

BERLIN, Germany—Performing ventricular tachycardia (VT) ablation before placement of a primary prevention implantable cardioverter-defibrillator (ICD) had a clinical benefit in a selected group of ...
Healio

Catheter ablation superior to antiarrhythmic drugs in VT with ischemic cardiomyopathy

Please provide your email address to receive an email when new articles are posted on . Catheter ablation improved outcomes vs. antiarrhythmic drugs in patients with VT and ischemic cardiomyopathy.
Medscape

High rate of VT recurrence in ARVD/C patients undergoing catheter ablation

Baltimore, MD - A report published this week has shown a high rate of ventricular tachycardia (VT) recurrence—as high as 75% at 14 months—in arrhythmogenic right ventricular dysplasia/cardiomyopathy ...
Healio

Trial reinforces superiority of VT ablation for patients with ischemic heart disease

Please provide your email address to receive an email when new articles are posted on . Meta-analysis further supports catheter ablation vs. drug therapy for management of ventricular arrythmias in ...
Morningstar

First in Human Ischemic VT Ablation Successfully Performed in iCMR

The Amsterdam UMC team, shown here, performed the VT ablation procedure following previous experiences performing atrial flutter and premature ventricular complex (PVC) ablation procedures guided by ...
Pharmabiz

Abbott begins patient enrollment in LESS-VT study to evaluate ablation as frontline treatment for complex cardiac arrhythmia

Abbott begins patient enrollment in LESS-VT study to evaluate ablation as frontline treatment for complex cardiac arrhythmia: Abbott Park, Illinois Thursday, November 22, 2018, 09 ...
Medscape

High Recurrence in VT Ablation Patients With Very Low EFs

May 6, 2011 (San Francisco, California) — Ablation of ventricular tachycardia (VT) in patients with verylow ejection fractions (EFs) results in high rates of early recurrence compared with individuals ...
MedPage Today

Impella Not Linked to Better VT Ablation Outcomes

NEW ORLEANS – The Impella 5.0 and 5.5 left ventricular assist device failed to measure up on outcomes when used for high-risk patients undergoing ventricular tachycardia (VT) ablation therapies, ...
Business Wire

Thermedical’s Groundbreaking SERF Ablation System Earns FDA’s Breakthrough Device Designation

WALTHAM, Mass.--(BUSINESS WIRE)--Thermedical ®, a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT), today announced that it has received Breakthrough Device ...
TCTMD

Ultralow-Temperature Cryoablation Promising for Monomorphic VT

BERLIN, Germany—Treatment of monomorphic ventricular tachycardia (VT) with a novel ultralow-temperature cryoablation catheter (vCLAS; Adagio Medical) appears to be safe and effective in patients with ...
Business Wire

Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM; “Adagio Medical”, “Adagio” or the “Company”), a leading innovator in catheter ablation technologies, today announced ...
MarketWatch

Thermedical Successfully Completes Feasibility Study for Treating Cardiac Arrhythmias Using Pulsed Field Ablation in Combination with SERF Ablation

Thermedical(R), a developer of advanced thermal-ablation systems to treat ventricular arrhythmias, announced today that it has completed a feasibility study utilizing Pulsed Field Ablation (PFA) ...